Skip to main content

Table 2 Main patient and tumor characteristics

From: Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery

Age (years) median (range) 66 (51-87)
Histology Ductal/other 48/9
Estrogen receptor RE+/RE- 52/5
Progesteron receptor RP+/RP- 45/12
Tumor stage Tis/T1/T2 1/48/8
Nodal stage N0/N1 54/3
Chemotherapy yes/no 15/42
  CMF 5
  FEC 5
  EC 1
  EC+ Docetaxel 4
Hormone-therapy yes/no 52/5
  1. Abbreviations: CMF: Cyclophosphamide (600 mg/m2, Methotrexate 40 mg/m2, 5-FU 600 mg/m2 d 1 and d 8 q 4 weeks × 6); FEC (5-FU 600 mg/m2, Epirubicin 60 mg/m2, Cyclophosphamide 600 mg/m2 d 1 q 3 weeks × 6); EC (Epirubicin 60 mg/m2, Cyclophosphamide 600 mg/m2 d1 q 3 weeks × 4); EC+ Docetaxel : EC followed by Docetaxel (100 mg/m2 d1 q 3 weeks × 4)